The biotechnology industry is one of the major contributors to the growth of the global life science industry. In the past few years, the healthcare industry has seen the emergence of several biologic molecules. Moreover, new drug development research is highly focused on biological products. Over the last decade, over 200 biologics have been approved by the US FDA.

The biopharmaceutical industry has witnessed the emergence of a new class of therapeutics showing significant potential in new treatments in oncology, diabetes, and other disease areas. 

Currently, there are hundreds of monoclonal antibodies, vaccines, and biologics in clinical development. The faster approval of new drugs drives the demand for cleanrooms for their manufacturing. Also, since many of the biologics are pathogenic, it is essential to maintain aseptic conditions during their manufacturing. Thus, cleanrooms form an essential component in the manufacturing of biologics.

Download PDF Brochure @ 

North America is expected to hold the largest share for players operating in the Cleanroom Technologies Market.

North America accounted for the largest share of the market in 2020. Factors such as stringent regulatory standards for product approvals, technological advancements in cleanrooms, initiatives taken by private organizations to create awareness regarding cleanrooms, and growth of the healthcare sector on a global scale are among the few factors expected to contribute to the growth of this market.

The prominent players in the global Cleanroom Technologies Market are Azbil Corporation (Japan), Kimberly-Clark Corporation (US), Ardmac (Ireland), Clean Air Products (US), Labconco Corporation (US), Dynarex Corporation (US), DuPont de Nemours, Inc. (US), Illinois Tool Works, Inc. (US), Taikisha Ltd. (Japan), Exyte AG (Germany), COLANDIS GmbH (Germany), ABN Cleanroom Technology (Belgium), Clean Rooms International, Inc. (US), and, Bouygues Group (France).